Guardant Health
268 hedge funds and large institutions have $6.03B invested in Guardant Health in 2019 Q4 according to their latest regulatory filings, with 72 funds opening new positions, 106 increasing their positions, 57 reducing their positions, and 43 closing their positions.
86% more repeat investments, than reductions
Existing positions increased: 106 | Existing positions reduced: 57
67% more first-time investments, than exits
New positions opened: 72 | Existing positions closed: 43
44% more funds holding in top 10
Funds holding in top 10: 9 → 13 (+4)
28% more capital invested
Capital invested by funds: $4.72B → $6.03B (+$1.31B)
11% more funds holding
Funds holding: 242 → 268 (+26)
2.66% more ownership
Funds ownership: 79.45% → 82.11% (+2.7%)
37% less call options, than puts
Call options by funds: $47.5M | Put options by funds: $75.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Coatue Management
New York
|
+$83.5M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$77.7M |
| 3 |
FAM
Fred Alger Management
New York
|
+$77.7M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$69.2M |
| 5 |
BlackRock
New York
|
+$65.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VS
VK Services
Menlo Park,
California
|
-$142M |
| 2 |
JP Morgan Chase
New York
|
-$120M |
| 3 |
SUT
SC US (TTGP)
Menlo Park,
California
|
-$57M |
| 4 |
Jennison Associates
New York
|
-$51.4M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$48.3M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIC
301
Ameritas Investment Company
Lincoln,
Nebraska
| – | -$57K | -896 | Closed |
|
|
CIAS
302
Capital Investment Advisory Services
Raleigh,
North Carolina
| – | -$45K | -700 | Closed |
|
|
CCA
303
Catalyst Capital Advisors
Huntington,
New York
| – | -$13K | -211 | Closed |
|
304
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$3K | -50 | Closed |
|
|
CFG
305
Citizens Financial Group
Providence,
Rhode Island
| – | -$1K | -13 | Closed |
|
|
PCM
306
Prelude Capital Management
New York
| – | -$1K | -11 | Closed |
|
GH Hedge Fund Activity: Q4 2019 in Review
268 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q4 2019, worth a combined $6.03B — up 28% from $4.72B a quarter earlier.
Buyers outnumbered sellers: 72 funds opened new GH positions and 43 closed out — a net gain of 29 holders — while 106 added to existing stakes and 57 trimmed.
The largest buyer was Coatue Management, adding an estimated $83.5M. The largest seller was VK Services, cutting an estimated $142M.
- 268 institutional investors held Guardant Health (GH) as of Q4 2019, up from 242 in Q3 2019.
- Funds reported $6.03B of Guardant Health stock for Q4 2019, up 28% quarter-over-quarter.
- 72 funds opened new Guardant Health positions in Q4 2019 and 43 closed out, a net change of +29 holders.
- The largest Guardant Health buyer in Q4 2019 was Coatue Management, an estimated $83.5M added.
- The largest Guardant Health seller in Q4 2019 was VK Services, an estimated $142M sold.
Based on aggregated 13F filings for Q4 2019.